Copyright
©The Author(s) 2022.
World J Gastroenterol. Nov 7, 2022; 28(41): 5944-5956
Published online Nov 7, 2022. doi: 10.3748/wjg.v28.i41.5944
Published online Nov 7, 2022. doi: 10.3748/wjg.v28.i41.5944
Characteristics | No TIPS | TIPS | P value |
Patients | 214 | 214 | |
Male | 142 (66%) | 153 (71%) | 0.30 |
Age (yr) | 59.4 (26.4-93.4) | 59.1 (29.9-80.7) | 0.14 |
Cause of cirrhosis | 0.26 | ||
-Alcohol | 163 (76%) | 179 (84%) | |
-Viral hepatitis | 8 (4%) | 4 (2%) | |
-Other | 43 (20%) | 31 (14%) | |
Child points (min-max) | 9 (7-14) | 9 (7-14) | 0.76 |
Hepatic encephalopathy (west-haven) | 0.65 | ||
-None | 173 (81%) | 165 (77%) | |
-Grade 1-2 | 22 (10%) | 30 (14%) | |
-Grade 3-4 | 19 (9%) | 19 (9%) | |
ACLF grade at hospital admission | 0.37 | ||
-No ACLF | 176 (82%) | 173 (81%) | |
-AACLF 1 | 36 (17%) | 39 (18%) | |
-ACLF 2 | 2 (1%) | 1 (0.5%) | |
-ACLF 3 | 0 (0%) | 1 (0.5%) | |
Laboratory findings | |||
-Meld | 14 (7-36) | 14 (7-40) | 0.97 |
-Total bilirubin (μmol/L) | 29.7 (5.9-261.0) | 28.1 (6.1-688.5) | 0.10 |
-Creatinine (μmol/L) | 90.9 (23.1-781.0) | 107.0 (42.3-783.5) | 0.08 |
-INR | 1.32 (0.92-2.41) | 1.28 (0.97-2.50) | 0.28 |
-Sodium (mmol/L) | 135 (106-144) | 133 (115-146) | 0.10 |
-Albumin (g/L) | 24.3 (7.9-48.7); NA: 27 | 26.1 (11.0-39.6); NA: 23 | 0.61 |
-CRP (mg/L) | 18.7 (1.0-283.0) | 18.0 (2.0-181.0) | 0.10 |
-Hemoglobin (mmol/L) | 6.8 (2.1-9.8) | 6.7 (3.4-10.0) | 0.43 |
-Platelets (Gpt/L) | 141.0 (23.0-715.0) | 154.0 (13.0-668.0) | 0.08 |
-Leucocytes (Gpt/L) | 7.58 (1.34-44.90) | 7.34 (2.72-33.20) | 0.98 |
- Citation: Philipp M, Blattmann T, Bienert J, Fischer K, Hausberg L, Kröger JC, Heller T, Weber MA, Lamprecht G. Transjugular intrahepatic portosystemic shunt vs conservative treatment for recurrent ascites: A propensity score matched comparison. World J Gastroenterol 2022; 28(41): 5944-5956
- URL: https://www.wjgnet.com/1007-9327/full/v28/i41/5944.htm
- DOI: https://dx.doi.org/10.3748/wjg.v28.i41.5944